These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 33775708

  • 1. Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
    Inker LA, Heerspink HJL, Tighiouart H, Chaudhari J, Miao S, Diva U, Mercer A, Appel GB, Donadio JV, Floege J, Li PKT, Maes BD, Locatelli F, Praga M, Schena FP, Levey AS, Greene T.
    Am J Kidney Dis; 2021 Sep; 78(3):340-349.e1. PubMed ID: 33775708
    [Abstract] [Full Text] [Related]

  • 2. Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.
    Inker LA, Mondal H, Greene T, Masaschi T, Locatelli F, Schena FP, Katafuchi R, Appel GB, Maes BD, Li PK, Praga M, Del Vecchio L, Andrulli S, Manno C, Gutierrez E, Mercer A, Carroll KJ, Schmid CH, Levey AS.
    Am J Kidney Dis; 2016 Sep; 68(3):392-401. PubMed ID: 27032886
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.
    Thompson A, Carroll K, A Inker L, Floege J, Perkovic V, Boyer-Suavet S, W Major R, I Schimpf J, Barratt J, Cattran DC, S Gillespie B, Kausz A, W Mercer A, Reich HN, H Rovin B, West M, Nachman PH.
    Clin J Am Soc Nephrol; 2019 Mar 07; 14(3):469-481. PubMed ID: 30635299
    [Abstract] [Full Text] [Related]

  • 6. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):947-955. PubMed ID: 27026518
    [Abstract] [Full Text] [Related]

  • 7. Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.
    Heerspink HJL, Inker LA, Tighiouart H, Collier WH, Haaland B, Luo J, Appel GB, Chan TM, Estacio RO, Fervenza F, Floege J, Imai E, Jafar TH, Lewis JB, Kam-Tao Li P, Locatelli F, Maes BD, Perna A, Perrone RD, Praga M, Schena FP, Wanner C, Xie D, Greene T, on behalf of CKD-EPI CT .
    J Am Soc Nephrol; 2023 Jun 01; 34(6):955-968. PubMed ID: 36918388
    [Abstract] [Full Text] [Related]

  • 8. First-year GFR slope and long-term renal outcome in IgA nephropathy.
    Lee K, Shin J, Park J, Hwang S, Jang HR, Huh W, Kwon GY, Kim YG, Oh HY, Lee JE, Kim DJ.
    Eur J Clin Invest; 2018 Jun 01; 48(6):e12936. PubMed ID: 29660832
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Tang C, Chen P, Si FL, Lv JC, Shi SF, Zhou XJ, Liu LJ, Zhang H.
    Am J Kidney Dis; 2024 Aug 01; 84(2):170-178.e1. PubMed ID: 38364955
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive agents for treating IgA nephropathy.
    Natale P, Palmer SC, Ruospo M, Saglimbene VM, Craig JC, Vecchio M, Samuels JA, Molony DA, Schena FP, Strippoli GF.
    Cochrane Database Syst Rev; 2020 Mar 12; 3(3):CD003965. PubMed ID: 32162319
    [Abstract] [Full Text] [Related]

  • 12. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S, Li JP.
    Trials; 2020 Jan 06; 21(1):31. PubMed ID: 31907076
    [Abstract] [Full Text] [Related]

  • 13. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial.
    Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN, Sui GL, Chen YQ, Lv JC, Zhang H.
    Am J Kidney Dis; 2019 Jul 06; 74(1):15-22. PubMed ID: 30922594
    [Abstract] [Full Text] [Related]

  • 14. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.
    Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM.
    Nephrol Dial Transplant; 2002 Jul 06; 17(7):1197-203. PubMed ID: 12105241
    [Abstract] [Full Text] [Related]

  • 15. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
    Lambers Heerspink HJ, Tighiouart H, Sang Y, Ballew S, Mondal H, Matsushita K, Coresh J, Levey AS, Inker LA.
    Am J Kidney Dis; 2014 Dec 06; 64(6):860-6. PubMed ID: 25441439
    [Abstract] [Full Text] [Related]

  • 16. GFR slope as a surrogate endpoint for CKD progression in clinical trials.
    Inker LA, Chaudhari J.
    Curr Opin Nephrol Hypertens; 2020 Nov 06; 29(6):581-590. PubMed ID: 33009129
    [Abstract] [Full Text] [Related]

  • 17. An update on predicting renal progression in IgA nephropathy.
    Barbour S, Reich H.
    Curr Opin Nephrol Hypertens; 2018 May 06; 27(3):214-220. PubMed ID: 29432215
    [Abstract] [Full Text] [Related]

  • 18. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):973-981. PubMed ID: 27129712
    [Abstract] [Full Text] [Related]

  • 19. GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials.
    Inker LA, Lambers Heerspink HJ, Mondal H, Schmid CH, Tighiouart H, Noubary F, Coresh J, Greene T, Levey AS.
    Am J Kidney Dis; 2014 Dec 06; 64(6):848-59. PubMed ID: 25441438
    [Abstract] [Full Text] [Related]

  • 20. The Validity of Drug Effects on Proteinuria, Albuminuria, Serum Creatinine, and Estimated GFR as Surrogate End Points for ESKD: A Systematic Review.
    Palmer SC, Ruospo M, Teixeira-Pinto A, Craig JC, Macaskill P, Strippoli GFM.
    Am J Kidney Dis; 2018 Dec 06; 72(6):779-789. PubMed ID: 30149958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.